Liposomal vaccine formulations as prophylactic agents: design considerations for modern vaccines


• We accept pre-submission inquiries •



Yüklə 1,05 Mb.
Pdf görüntüsü
səhifə31/31
tarix02.06.2023
ölçüsü1,05 Mb.
#123390
1   ...   23   24   25   26   27   28   29   30   31
10.1186 2Fs12951-017-0319-9


We accept pre-submission inquiries

Our selector tool helps you to find the most relevant journal

We provide round the clock customer support 

Convenient online submission

Thorough peer review

Inclusion in PubMed and all major indexing services 

Maximum visibility for your research
Submit your manuscript at
www.biomedcentral.com/submit
Submit your next manuscript to BioMed Central 
and we will help you at every step:
essential for the biosynthesis of oxygenated mycolic acids in Mycobac-
terium tuberculosis. J Biol Chem. 2006;281:4434–45.
131. Procop GW. HIV and mycobacteria. Semin Diagn Pathol. 2017;34:332–9.
132. Perronne C, Zahraoui M, Leport C, Salmon D, Pangon B, Bricaire F, Vilde 
JL. Tuberculosis in 30 patients with HIV infection. Ann Med Interne. 
1988;139:375–6.
133. Haegi V. Septic tuberculosis in HIV-infection. Schweiz Med Wochenschr. 
1987;117:1297–301.
134. Martin-Bertelsen B, Korshohn KS, Roces CB, Nielsen MH, Christensen 
D, Franzyk H, Yaghmur A, Foged C. Nano-self-assemblies based on 
synthetic analogues of mycobacterial monomycoloyl glycerol and 
DDA: supramolecular structure and adjuvant efficacy. Mol Pharm. 
2016;13:2771–81.
135. Larrouy-Maumus G, Layre E, Clark S, Prandi J, Rayner E, Lepore M, 
de Libero G, Williams A, Puzo G, Gilleron M. Protective efficacy of a 
lipid antigen vaccine in a guinea pig model of tuberculosis. Vaccine. 
2017;35:1395–402.

Document Outline

  • Liposomal vaccine formulations as prophylactic agents: design considerations for modern vaccines
    • Abstract 
    • Background
    • Liposome design
    • Liposome-immune cell interactions to improve vaccine effectiveness
      • Vaccine interaction with neutrophils, monocytes and APCs
      • Mannosylated liposomes
    • Viral infections and liposomes-based vaccines
      • Hepatitis
      • Influenza
      • Respiratory syncytial virus
    • Bacterial infections and liposomal vaccines
    • Liposomal-based vaccines in fungal infection treatment
    • Parasitic infections and liposomal vaccines
    • DDA-based cationic liposomal vaccines for the treatment of tuberculosis
    • Conclusion
    • Authors’ contributions
    • References

Yüklə 1,05 Mb.

Dostları ilə paylaş:
1   ...   23   24   25   26   27   28   29   30   31




Verilənlər bazası müəlliflik hüququ ilə müdafiə olunur ©azkurs.org 2024
rəhbərliyinə müraciət

gir | qeydiyyatdan keç
    Ana səhifə


yükləyin